BridgeBio Pharma LLC
Insider Reports History
- Location
- Palo Alto, CA
- Signature
- /s/ Neil Kumar, Chief Executive Officer of BridgeBio Pharma LLC
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by BridgeBio Pharma LLC:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | 10%+ Owner | Common Stock | 14,589,846 | $156,363,757 | $10.72 | 10 Oct 2025 | Direct |
Insider Reports Filed by BridgeBio Pharma LLC
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HLXB | BridgeBio Oncology Therapeutics, Inc. | 10 Oct 2025 | 1 | $0 | 4 | 10%+ Owner | 16 Oct 2025, 17:54 |
| HLXB | BridgeBio Oncology Therapeutics, Inc. | 11 Aug 2025 | 0 | $0 | 3 | 10%+ Owner | 18 Aug 2025, 17:16 |